Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are gut-derived incretin hormones that facilitate glucose-stimulated insulin secretion
Effects: By activating GLP-1 receptors, Tirzepatide increases insulin secretion in response to meals, reduces glucagon release (which helps lower blood sugar), and slows gastric emptying (promoting feelings of fullness)
Safety Considerations: GLP-1 Medications and Alcohol Use Understanding the safety profile of GLP-1 receptor agonists in the context of alcohol consumption is essential for both patients and healthcare professionals
The effectiveness of these medications may depend heavily on consistency, said Thomas H
Most of these drugs produced by compounding pharmacies have been sold to patients via telehealth companies such as Ro, Sesame, Hims & Hers, and even Weight Watchers at a substantial discount ($200-300/month compared to the Wegovy list price of about $1,350/month). In the US, he added, We can expect at least 15 new AOM [anti-obesity medications] drugs on the market within the next five years
